Scherl E - Search Results

1

Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease.

Wong R, Qin L, Pan Y, Mahtani P, Longman R, Lukin D, Scherl E, Battat R. Wong R, et al. Among authors: scherl e. J Clin Med. 2023 Oct 27;12(21):6796. doi: 10.3390/jcm12216796. J Clin Med. 2023. PMID: 37959261 Free PMC article.

2

Withdrawal: Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease: Evidence for involvement of the transcription factor Egr-1.

Subbaramaiah K, Yoshimatsu K, Scherl E, Das KM, Glazier KD, Golijanin D, Soslow RA, Tanabe T, Naraba H, Dannenberg AJ. Subbaramaiah K, et al. Among authors: scherl e. J Biol Chem. 2020 Jan 3;295(1):293. doi: 10.1074/jbc.W119.012138. J Biol Chem. 2020. PMID: 31900375 Free PMC article. No abstract available.

3

Crohn's disease is associated with restless legs syndrome.

Weinstock LB, Bosworth BP, Scherl EJ, Li E, Iroku U, Munsell MA, Mullin GE, Walters AS. Weinstock LB, et al. Among authors: scherl ej. Inflamm Bowel Dis. 2010 Feb;16(2):275-9. doi: 10.1002/ibd.20992. Inflamm Bowel Dis. 2010. PMID: 19575360 Free PMC article.

4

Pseudodiverticula secondary to injection sclerotherapy.

Scherl EJ, Fabry TL. Scherl EJ, et al. J Clin Gastroenterol. 1983 Oct;5(5):401-3. doi: 10.1097/00004836-198310000-00005. J Clin Gastroenterol. 1983. PMID: 6415157

5

Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide.

Jahraus CD, Rubin DT, Scherl EJ, Bettenhausen D. Jahraus CD, et al. Gastroenterology. 2005 Aug;129(2):770-2. doi: 10.1016/j.gastro.2005.06.042. Gastroenterology. 2005. PMID: 16083743 No abstract available.

6

Bacteremia after endoscopic injection sclerosis.

Cohen LB, Korsten MA, Scherl EJ, Velez ME, Fisse RD, Arons EJ. Cohen LB, et al. Among authors: scherl ej. Gastrointest Endosc. 1983 Aug;29(3):198-200. doi: 10.1016/s0016-5107(83)72584-8. Gastrointest Endosc. 1983. PMID: 6618116

7

Esophageal motility and symptoms after endoscopic injection sclerotherapy.

Cohen LB, Simon C, Korsten MA, Scherl EJ, Skorniky J, Guelrud MB, Waye JD. Cohen LB, et al. Among authors: scherl ej. Dig Dis Sci. 1985 Jan;30(1):29-32. doi: 10.1007/BF01318367. Dig Dis Sci. 1985. PMID: 3871190

8

Avoidance of steroids by the early use of infliximab and 6-mercaptopurine in an adolescent with active Crohn's colitis.

Persley K, Scherl E, Rubin P. Persley K, et al. Among authors: scherl e. Am J Gastroenterol. 2001 Dec;96(12):3444-5. doi: 10.1111/j.1572-0241.2001.05380.x. Am J Gastroenterol. 2001. PMID: 11774971 No abstract available.

9

CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22.

Longman RS, Diehl GE, Victorio DA, Huh JR, Galan C, Miraldi ER, Swaminath A, Bonneau R, Scherl EJ, Littman DR. Longman RS, et al. Among authors: scherl ej. J Exp Med. 2014 Jul 28;211(8):1571-83. doi: 10.1084/jem.20140678. Epub 2014 Jul 14. J Exp Med. 2014. PMID: 25024136 Free PMC article.

10

Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents.

Axelrad J, Bernheim O, Colombel JF, Malerba S, Ananthakrishnan A, Yajnik V, Hoffman G, Agrawal M, Lukin D, Desai A, McEachern E, Bosworth B, Scherl E, Reyes A, Zaidi H, Mudireddy P, DiCaprio D, Sultan K, Korelitz B, Wang E, Williams R, Chen L, Katz S, Itzkowitz S; New York Crohn's and Colitis Organization. Axelrad J, et al. Among authors: scherl e. Clin Gastroenterol Hepatol. 2016 Jan;14(1):58-64. doi: 10.1016/j.cgh.2015.07.037. Epub 2015 Aug 3. Clin Gastroenterol Hepatol. 2016. PMID: 26247164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page